Top Page
Ramsay Health Care
(Sydney:RHC)
Ramsay Health Care (RHC) vs. iShares MSCI Australia ETF (EWA)
Ramsay Health Care Business Overview & Revenue Model
Ramsay Health Care Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 17.79B | 17.79B | 16.66B | 14.96B | 13.08B | 12.86B |
| Gross Profit | 2.12B | 2.12B | 1.61B | 1.27B | 9.97B | 1.59B |
| EBITDA | 1.59B | 1.59B | 1.81B | 1.78B | 1.61B | 1.80B |
| Net Income | 24.00M | 24.00M | 888.70M | 298.10M | 274.00M | 449.00M |
Balance Sheet | ||||||
| Total Assets | 22.48B | 22.48B | 20.89B | 21.03B | 19.47B | 19.32B |
| Cash, Cash Equivalents and Short-Term Investments | 785.60M | 785.60M | 662.30M | 656.10M | 314.20M | 1.00B |
| Total Debt | 12.16B | 12.16B | 10.94B | 11.89B | 10.70B | 10.55B |
| Total Liabilities | 16.77B | 16.77B | 15.37B | 16.21B | 14.95B | 14.77B |
| Stockholders Equity | 5.02B | 5.02B | 4.90B | 4.15B | 3.93B | 4.03B |
Cash Flow | ||||||
| Free Cash Flow | 704.20M | 704.20M | 539.00M | 558.70M | 7.00M | 852.30M |
| Operating Cash Flow | 1.48B | 1.48B | 1.29B | 1.28B | 715.50M | 1.48B |
| Investing Cash Flow | -777.40M | -765.30M | 159.70M | -713.80M | 30.00M | -2.50B |
| Financing Cash Flow | -631.20M | -631.20M | -1.45B | -242.40M | -1.41B | 584.00M |
Ramsay Health Care Technical Analysis
Ramsay Health Care Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | AU$524.72M | 15.63 | 18.59% | 4.90% | 6.73% | 37.16% | |
64 Neutral | AU$10.27B | 19.43 | 6.32% | 5.12% | 9.44% | -0.37% | |
55 Neutral | AU$977.07M | 172.37 | 0.94% | 2.63% | 33.54% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | AU$2.26B | 45.97 | ― | 2.11% | 14.61% | ― | |
50 Neutral | $7.10B | 1,044.59 | 0.38% | 2.59% | 6.82% | -99.27% | |
48 Neutral | €635.37M | -1.21 | -67.21% | ― | -23.02% | 33.11% |
Ramsay Health Care Corporate Events
Ramsay Health Care Limited has announced a new dividend distribution for its security holders, with a distribution amount of AUD 2.9642 per unit. The payment is scheduled for April 20, 2026, and pertains to a six-month period ending on April 19, 2026. This announcement reflects the company’s ongoing commitment to providing returns to its investors and may influence its market positioning by demonstrating financial stability and shareholder value.
The most recent analyst rating on (AU:RHC) stock is a Hold with a A$33.00 price target. To see the full list of analyst forecasts on Ramsay Health Care stock, see the AU:RHC Stock Forecast page.
Ramsay Health Care has issued a correction to its 2025 Annual Report concerning inaccuracies in the tables listing the top 20 ordinary shareholders and CARES holders. The correction involves the names and order of these shareholders, which were previously incorrect. This update ensures transparency and accuracy in shareholder information, which is crucial for maintaining investor trust and compliance with reporting standards.
The most recent analyst rating on (AU:RHC) stock is a Hold with a A$37.00 price target. To see the full list of analyst forecasts on Ramsay Health Care stock, see the AU:RHC Stock Forecast page.
Ramsay Health Care Limited announced the cessation of several performance rights, totaling 199,893 securities, due to unmet conditions. This development could impact the company’s financial strategies and stakeholder expectations, as performance rights are often linked to employee incentives and company performance metrics.
The most recent analyst rating on (AU:RHC) stock is a Hold with a A$32.00 price target. To see the full list of analyst forecasts on Ramsay Health Care stock, see the AU:RHC Stock Forecast page.
Ramsay Health Care has announced its 2025 Annual General Meeting (AGM) scheduled for November 25, 2025, in Sydney, Australia. Shareholders are encouraged to participate either in person or via a live webcast, with options to appoint proxies and submit questions. This meeting is a significant event for stakeholders, providing insights into the company’s strategic direction and operational focus.
The most recent analyst rating on (AU:RHC) stock is a Hold with a A$36.00 price target. To see the full list of analyst forecasts on Ramsay Health Care stock, see the AU:RHC Stock Forecast page.
Ramsay Health Care announced the retirement of James McMurdo as a Non-executive Director after the 2025 Annual General Meeting. McMurdo, who joined the board in 2019 and served on the Audit Committee, contributed significantly to the company’s strategic and financial growth. Ramsay’s Chair, David Thodey, emphasized the importance of ongoing board renewal to maintain a balanced mix of skills and perspectives, ensuring effective governance in a dynamic environment.
The most recent analyst rating on (AU:RHC) stock is a Hold with a A$36.00 price target. To see the full list of analyst forecasts on Ramsay Health Care stock, see the AU:RHC Stock Forecast page.
Ramsay Health Care has released its 2025 Annual Report, emphasizing its commitment to sustainable development and aligning its operations with the United Nations Sustainable Development Goals. The report outlines key value drivers, business strategies, and risks, providing stakeholders with insights into the company’s performance and future outlook. The Annual General Meeting is scheduled for November, and the company continues to provide financial updates and dividend payment schedules, reflecting its ongoing transparency and engagement with investors.
The most recent analyst rating on (AU:RHC) stock is a Hold with a A$35.00 price target. To see the full list of analyst forecasts on Ramsay Health Care stock, see the AU:RHC Stock Forecast page.
Ramsay Health Care announced its financial results for the year ending June 30, 2025, highlighting that its Underlying Net Profit After Tax (NPAT) and Underlying Earnings Before Interest and Tax (EBIT) were in line with market expectations based on sell-side analyst forecasts. The company reported a Statutory NPAT of $24.0 million, which was significantly impacted by a non-cash impairment of $291 million related to its UK operations. This impairment led analysts to focus on Underlying NPAT and EBIT as more relevant indicators of the company’s performance, with Ramsay’s earnings closely aligning with consensus estimates.
The most recent analyst rating on (AU:RHC) stock is a Hold with a A$35.00 price target. To see the full list of analyst forecasts on Ramsay Health Care stock, see the AU:RHC Stock Forecast page.
Ramsay Health Care Limited is a global healthcare provider operating in Australia, the UK, and Europe, known for its high standards of quality and safety in healthcare services. In its latest earnings report for the fiscal year ending June 2025, Ramsay Health Care reported a 6.8% increase in revenue from contracts with customers, reaching A$17.8 billion. However, the company faced challenges with a significant drop in net profit after tax from continuing operations, which fell by 82.4% to A$46.3 million. Key financial metrics showed mixed results, with underlying NPAT from continuing operations excluding non-recurring items increasing by 1.7% to A$305.3 million, driven by improvements in the UK acute hospitals and Australian private hospital activities. Despite these gains, the company faced setbacks from higher financing costs and an increased effective tax rate. Looking ahead, Ramsay Health Care anticipates activity growth across all regions, with a focus on operational improvements and strategic priorities aligned with its 2030 strategy. The company expects continued momentum in its private hospital portfolio in Australia, although challenges remain with public hospital operations and cost pressures.
Ramsay Health Care Limited has announced a new dividend distribution of AUD 0.40 per share for its ordinary fully paid securities. The dividend relates to the financial period ending June 30, 2025, with key dates including an ex-date of September 3, 2025, a record date of September 4, 2025, and a payment date of September 25, 2025. This announcement may impact the company’s financial operations and stakeholder returns.
The most recent analyst rating on (AU:RHC) stock is a Hold with a A$46.55 price target. To see the full list of analyst forecasts on Ramsay Health Care stock, see the AU:RHC Stock Forecast page.
Ramsay Health Care released its FY25 results presentation, highlighting the company’s financial position and strategies as of June 30, 2025. The presentation, which includes forward-looking statements, provides insights into the company’s operational performance and strategic direction, though it cautions against undue reliance on these projections due to potential risks and uncertainties.
The most recent analyst rating on (AU:RHC) stock is a Hold with a A$46.55 price target. To see the full list of analyst forecasts on Ramsay Health Care stock, see the AU:RHC Stock Forecast page.
Ramsay Health Care has reported a solid performance in its core hospital businesses in Australia and the UK, despite challenges faced by its Elysium and Ramsay Santé divisions. The company is undergoing a multi-year transformation, focusing on improving its Australian hospital business, enhancing capital discipline, and evolving its operational culture. Key strategic initiatives include major negotiations with private health insurers, restructuring its psychology business, and implementing ‘Big 5’ hospital operations initiatives. The company has also made key executive appointments to support its transformation efforts. Financially, Ramsay reported a significant drop in net profit after tax due to non-recurring items, but underlying profit from continuing operations showed a modest increase. The company remains focused on executing its strategic priorities to improve financial and operational performance.
The most recent analyst rating on (AU:RHC) stock is a Hold with a A$46.55 price target. To see the full list of analyst forecasts on Ramsay Health Care stock, see the AU:RHC Stock Forecast page.
Ramsay Health Care has released its preliminary final report for the year ending June 30, 2025, indicating a comprehensive overview of its financial performance. The announcement, which includes a presentation by key executives, highlights the company’s commitment to transparency and stakeholder engagement, potentially impacting its market position and investor relations.
The most recent analyst rating on (AU:RHC) stock is a Hold with a A$46.55 price target. To see the full list of analyst forecasts on Ramsay Health Care stock, see the AU:RHC Stock Forecast page.